-
Founded in:
1993-05-18 -
Country:
China -
Address:
No. 21, Fangzheng Avenue, Shuitu Town, Beibei District, Chongqing -
Tax NO.:
91500000450533779H -
Registered Funds:
595.987425 yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Hydroxyethyl starch 130/0.4 |
This product is a blood volume expander. Its volume expansion effect and blood dilution effect depend on the molecular weight, degree of substitution, substitution pattern and drug concentration, as well as the dosage and infusion rate.
More
This product is a blood volume expander. Its volume expansion effect and blood dilution effect depend on the molecular weight, degree of substitution, substitution pattern and drug concentration, as well as the dosage and infusion rate. |
30g | 0 | |
| Sodium chloride |
This product is a blood volume expander and participates in maintaining blood volume and electrolyte balance.
More
This product is a blood volume expander and participates in maintaining blood volume and electrolyte balance. |
4.5g | 7647-14-5 | 43 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Clindamycin palmitate hydrochloride |
This product is a derivative of clindamycin. It has no antibacterial activity in vitro. It is hydrolyzed by esterase in vivo to form clindamycin and exert its antibacterial activity. The mechanism of action of clindamycin is to inhibit the synthesis of bacterial proteins. It mainly acts on Gram-positive cocci and anaerobic infections. It has good antibacterial effects on Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus pyogenes, etc. It is moderately sensitive to Haemophilus influenzae and Neisseria gonorrhoeae. Some erythromycin-resistant Staphylococcus aureus and Staphylococcus epidermidis are still sensitive to this product. It has good antibacterial effects on both Gram-negative and Gram-positive anaerobic bacteria.
More
This product is a derivative of clindamycin. It has no antibacterial activity in vitro. It is hydrolyzed by esterase in vivo to form clindamycin and exert its antibacterial activity. The mechanism of action of clindamycin is to inhibit the synthesis of bacterial proteins. It mainly acts on Gram-positive cocci and anaerobic infections. It has good antibacterial effects on Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus pyogenes, etc. It is moderately sensitive to Haemophilus influenzae and Neisseria gonorrhoeae. Some erythromycin-resistant Staphylococcus aureus and Staphylococcus epidermidis are still sensitive to this product. It has good antibacterial effects on both Gram-negative and Gram-positive anaerobic bacteria. |
25507-04-4 | 18 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Clindamycin palmitate hydrochloride |
This product is a derivative of clindamycin. It is hydrolyzed by esterase in the body to form clindamycin and exert its antibacterial activity. The mechanism of action of clindamycin is to inhibit the synthesis of bacterial proteins. It mainly acts on Gram-positive cocci and anaerobic infections. It has good antibacterial effects on Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus pyogenes, etc., and is moderately sensitive to Haemophilus influenzae and Neisseria gonorrhoeae. Some erythromycin-resistant Staphylococcus aureus and Staphylococcus epidermidis are still sensitive to this product. It has good antibacterial effects on both Gram-negative and Gram-positive anaerobic bacteria.
More
This product is a derivative of clindamycin. It is hydrolyzed by esterase in the body to form clindamycin and exert its antibacterial activity. The mechanism of action of clindamycin is to inhibit the synthesis of bacterial proteins. It mainly acts on Gram-positive cocci and anaerobic infections. It has good antibacterial effects on Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus pyogenes, etc., and is moderately sensitive to Haemophilus influenzae and Neisseria gonorrhoeae. Some erythromycin-resistant Staphylococcus aureus and Staphylococcus epidermidis are still sensitive to this product. It has good antibacterial effects on both Gram-negative and Gram-positive anaerobic bacteria. |
25507-04-4 | 18 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Vitamin E |
Participate in some metabolic reactions in the body. It can fight against the peroxidation of free radicals, resist aging, protect the skin, enhance ovarian function, and prevent habitual abortion.
More
Participate in some metabolic reactions in the body. It can fight against the peroxidation of free radicals, resist aging, protect the skin, enhance ovarian function, and prevent habitual abortion. |
2074-53-5 | 11 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sineptina |
This product is a macrolide antibiotic. Its mechanism of action is similar to that of erythromycin, and its antibacterial spectrum is also similar to that of erythromycin, but its antibacterial activity against most Gram-positive bacteria is slightly worse. Some erythromycin-resistant Staphylococcus aureus are still sensitive to kitasamycin. This product also has considerable activity against diphtheria, tetani, Neisseria gonorrhoeae, pertussis, Rickettsia and Chlamydia trachomatis.
More
This product is a macrolide antibiotic. Its mechanism of action is similar to that of erythromycin, and its antibacterial spectrum is also similar to that of erythromycin, but its antibacterial activity against most Gram-positive bacteria is slightly worse. Some erythromycin-resistant Staphylococcus aureus are still sensitive to kitasamycin. This product also has considerable activity against diphtheria, tetani, Neisseria gonorrhoeae, pertussis, Rickettsia and Chlamydia trachomatis. |
1392-21-8 | 8 |